Boston Criteria v2.0 for Cerebral Amyloid Angiopathy Without Hemorrhage: An MRI-Neuropathologic Validation Study.

Aaron R Switzer Charidimou AndreasStuart McCarterPrashanthi VemuriAivi T NguyenScott A PrzybelskiTimothy G LesnickAlejandro A RabinsteinRobert D BrownDavid S Knopman Ronald C Petersen Clifford R Jack Robert Ross Reichard Jonathan Graff-Radford

Published in: Neurology (2024)

The Boston criteria v2.0 have low accuracy in patients who are asymptomatic or only have cognitive symptoms. Additional biomarkers need to be explored to optimize CAA diagnosis in this population.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
magnetic resonance imaging
prognostic factors
peritoneal dialysis
physical activity
sleep quality
patient reported outcomes
cerebral blood flow